Autolus Limited Company
Autolus is a leader in T-cell programming and manufacturing technology.
Investment Stage:
N/A
Funding Status:
IPO
Headquarters:
United Kingdom
Industry:
Genomic and Epigenominc Instabillity
Number Of Exists:
N/A
Investor Type:
N/A
Technology:
Cell Therapies
Employee Number:
11-50
Founded Date:
2014